| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |